Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
Corcept Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 25, 2022
Corcept Therapeutics reported fiscal year 2021 executive compensation information on April 25, 2022.
In 2021, five executives at Corcept Therapeutics received on average a compensation package of $6.5M, a 94% increase compared to previous year.
Average pay of disclosed executives at Corcept Therapeutics
Joseph K. Belanoff, Chief Executive Officer, received $11M in total, which increased by 91% compared to 2020. 85% of Belanoff's compensation, or $9.3M, was in option awards. Belanoff also received $850K in bonus and $844K in salary.
Atabak Mokari, Chief Financial Officer, received a compensation package of $7M. 91% of the compensation package, or $6.4M, was in option awards.
Charles Robb, Secretary, earned $5.3M in 2021, a 80% increase compared to previous year.
Sean Maduck, Chief Commercial Officer, received $4.5M in 2021, which increases by 42% compared to 2020.
Hazel Hunt, Chief Scientific Officer, earned $4.5M in 2021, a 65% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 25, 2022.